Literature DB >> 26080460

Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model.

Ketpat Vejjasilpa1, Norased Nasongkla2, Chawan Manaspon1, Noppadol Larbcharoensub3, Atthaporn Boongird4, Suradej Hongeng5, Nipan Israsena6.   

Abstract

We investigate antitumor efficacy and 2D and 3D intratumoral distribution of 7-ethyl-10-hydroxycamptothecin (SN-38) from polymeric depots inside U-87MG xenograft tumor model in nude mice. Results showed that polymeric depots could be used to administer and controlled release of a large amount of SN-38 directly to the brain tumor model. SN-38 released from depots suppressed tumor growth, where the extent of suppression greatly depended on doses and the number of depot injections. Tumor suppression of SN-38 from depots was three-fold higher in animals which received double injections of depots at high dose (9.7 mg of SN-38) compared to single injection (2.2 mg). H&E staining of tumor sections showed that the area of tumor cell death/survival of the former group was two-fold higher than those of the latter group. Fluorescence imaging based on self-fluorescent property of SN-38 was used to evaluate the intratumoral distribution of this drug compared to histological results. The linear correlation between fluorescence intensity and the amount of SN-38 allowed quantitative determination of SN-38 in tumor tissues. Results clearly showed direct correlation between the amount of SN-38 in tumor sections and cancer cell death. Moreover, 3D reconstruction representing the distribution of SN-38 in tumors was obtained. Results from this study suggest the rationale for intratumoral drug administration and release of drugs inside tumor, which is necessary to design drug delivery systems with efficient antitumor activity.
© 2015 by the Society for Experimental Biology and Medicine.

Entities:  

Keywords:  Biodegradable polymer; SN-38; brain tumor model; drug delivery system; intratumoral

Mesh:

Substances:

Year:  2015        PMID: 26080460      PMCID: PMC4935348          DOI: 10.1177/1535370215590819

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  27 in total

Review 1.  Drug transport to brain with targeted liposomes.

Authors:  Anita Schnyder; Jörg Huwyler
Journal:  NeuroRx       Date:  2005-01

2.  Biocompatibility study of glycofurol in rat brains.

Authors:  Atthaporn Boongird; Norased Nasongkla; Suradej Hongeng; Nongyao Sukdawong; Waridtha Sa-Nguanruang; Noppadol Larbcharoensub
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

3.  Injectable intratumoral depot of thermally responsive polypeptide-radionuclide conjugates delays tumor progression in a mouse model.

Authors:  Wenge Liu; J Andrew MacKay; Matthew R Dreher; Mingnan Chen; Jonathan R McDaniel; Andrew J Simnick; Daniel J Callahan; Michael R Zalutsky; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2010-01-31       Impact factor: 9.776

4.  Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy.

Authors:  W Dang; T Daviau; H Brem
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

5.  HPLC method for determination of SN-38 content and SN-38 entrapment efficiency in a novel liposome-based formulation, LE-SN38.

Authors:  Tong Xuan; J Allen Zhang; Imran Ahmad
Journal:  J Pharm Biomed Anal       Date:  2006-01-18       Impact factor: 3.935

6.  Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro.

Authors:  Jingwei Xie; Chi-Hwa Wang
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

7.  Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma.

Authors:  Jun-ichiro Kuroda; Jun-ichi Kuratsu; Masahiro Yasunaga; Yoshikatsu Koga; Yohei Saito; Yasuhiro Matsumura
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

8.  Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.

Authors:  Puja Sapra; Hong Zhao; Mary Mehlig; Jennifer Malaby; Patricia Kraft; Clifford Longley; Lee M Greenberger; Ivan D Horak
Journal:  Clin Cancer Res       Date:  2008-03-15       Impact factor: 12.531

9.  HPLC analysis and extraction method of SN-38 in brain tumor model after injected by polymeric drug delivery system.

Authors:  Pinunta Nittayacharn; Chawan Manaspon; Suradej Hongeng; Norased Nasongkla
Journal:  Exp Biol Med (Maywood)       Date:  2014-07-02

10.  Effect of intratumoral injection of carboplatin combined with pluronic P85 or L61 on experimental colorectal carcinoma in rats.

Authors:  Tianyi M Krupka; Brent D Weinberg; Hanping Wu; Nicholas P Ziats; Agata A Exner
Journal:  Exp Biol Med (Maywood)       Date:  2007-07
View more
  5 in total

1.  Injectable SN-38-loaded Polymeric Depots for Cancer Chemotherapy of Glioblastoma Multiforme.

Authors:  Chawan Manaspon; Norased Nasongkla; Khuanjit Chaimongkolnukul; Pinunta Nittayacharn; Ketpat Vejjasilpa; Kanchana Kengkoom; Atthaporn Boongird; Suradej Hongeng
Journal:  Pharm Res       Date:  2016-08-05       Impact factor: 4.200

2.  Macroporous acrylamide phantoms improve prediction of in vivo performance of in situ forming implants.

Authors:  Christopher Hernandez; Natalia Gawlik; Monika Goss; Haoyan Zhou; Selva Jeganathan; Danielle Gilbert; Agata A Exner
Journal:  J Control Release       Date:  2016-10-11       Impact factor: 9.776

3.  Development of self-forming doxorubicin-loaded polymeric depots as an injectable drug delivery system for liver cancer chemotherapy.

Authors:  Pinunta Nittayacharn; Norased Nasongkla
Journal:  J Mater Sci Mater Med       Date:  2017-05-22       Impact factor: 3.896

4.  Injectable SN-38-embedded Polymeric Microparticles Promote Antitumor Efficacy against Malignant Glioma in an Animal Model.

Authors:  Yuan-Yun Tseng; Tao-Chieh Yang; Shu-Mei Chen; Shun-Tai Yang; Ya-Ling Tang; Shih-Jung Liu
Journal:  Pharmaceutics       Date:  2020-05-24       Impact factor: 6.321

5.  Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.

Authors:  Tao-Chieh Yang; Shih-Jung Liu; Wei-Lun Lo; Shu-Mei Chen; Ya-Ling Tang; Yuan-Yun Tseng
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.